Peptide compound·Best seller
Tirzepatide
Dual GIP/GLP-1 agonist. Stronger appetite regulation + glycemic control vs. semaglutide.
$299Starting · per vial
— Tracked fulfillment · COA included · Discreet packaging
Purity
USP / NF
Form
Compounded
Storage
Refrigerate
Grade
Prescription
— Overview
Tirzepatide at a glance.
Tirzepatide activates both GIP and GLP-1 receptors, producing greater weight-loss outcomes than semaglutide in head-to-head trials. Stria's protocol titrates from 2.5mg → 15mg over 6 months with monthly check-ins.
— Want supervision?
Pair Tirzepatide with a
physician-designed protocol.
Stria Performance and Complete tiers include physician-prescribed peptides with comprehensive labs and quarterly follow-up. Take the assessment to see which fits.